EUVIMEDEUVIMED entdecken
Multizentrische Studie

Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis

Gautier Marcq iD, Ronald Kool iD, Alice Dragomir iD, Girish S Kulkarni iD, Rodney H Breau iD, Michael Kim, Ionut Busca, Hamidreza Abdi iD, Mark Dawidek, Michael Uy, Gagan Fervaha iD, Nimira Alimohamed iD und 8 weitere

Journal of Clinical Oncology · 2025

DOI: 10.1200/jco.23.02718 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Clinical Oncology, 2025. Verfasst von Gautier Marcq und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, McGill University Health Centre, Montreal, Canada. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Lymphatic Irradiation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE The value of pelvic lymph node irradiation is debated for patients with muscle-invasive bladder cancer (MIBC) undergoing curative-intent radiation therapy (RT). We sought to compare the oncologic outcomes between bladder-only (BO)-RT and whole-pelvis (WP)-RT using a large Canadian multicenter collaborative database. PATIENTS AND METHODS The study cohort consisted of 809 patients with MIBC (cT2-4aN0-2M0) who underwent curative RT at academic centers across Canada. Patients were divided into two groups on the basis of the RT volume: WP-RT versus BO-RT. Inverse probability of treatment weighting (IPTW) and absolute standardized differences (ASDs) were used to balance covariates across treatment groups. Regression models were used to assess the effect of the RT volume on the rates of complete response (CR), cancer-specific survival (CSS), and overall survival (OS). RESULTS After exclusion criteria, 599 patients were included, of whom 369 (61.6%) underwent WP-RT. Patients receiving WP-RT were younger (ASD, 0.41) and more likely to have an Eastern Cooperative Oncology Group performance status of 0-1 (ASD, 0.21), clinical node-positive disease (ASD, 0.40), and lymphovascular invasion (ASD, 0.25). In addition, WP-RT patients were more commonly treated with neoadjuvant chemotherapy (ASD, 0.29) and concurrent chemotherapy (ASD, 0.44). In the IPTW cohort, BO-RT and WP-RT groups were well balanced (all pretreatment parameters with an ASD

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsLymphatic IrradiationHumansFemaleMaleAgedMiddle AgedNeoplasm InvasivenessPelvisCanadaTreatment OutcomeAged, 80 and overRetrospective Studies

Autor:innen und Institutionen

  • Department of Urology, McGill University Health Centre, Montreal, Canada.
  • Urology Department, Claude Huriez Hospital, CHU Lille, Lille, France.
  • CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, University of Lille, Lille, France.
  • Department of Abdominal Surgery, Erasto Gaertner Cancer Center, Curitiba, Brazil.
  • Department of Surgery (Urology), Princess Margaret Cancer Centre and the University Health Network, University of Toronto, Toronto, Canada.
  • Division of Urology, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada.

ORCID-Profile: Gautier Marcq, Ronald Kool, Alice Dragomir, Girish S Kulkarni, Rodney H Breau, Hamidreza Abdi, Gagan Fervaha, Nimira Alimohamed, Peter C Black, Fabio L Cury, Wassim Kassouf

Zitieren

APA

Marcq, G., Kool, R., Dragomir, A., Kulkarni, G. S., Breau, R. H., Kim, M., Busca, I., Abdi, H., Dawidek, M., Uy, M., Fervaha, G., Alimohamed, N., Izawa, J., Jeldres, C., Rendon, R., Shayegan, B., Siemens, R., Black, P. C., Cury, F. L., & Kassouf, W. (2025). Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis. Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.02718

Vancouver

Marcq G, Kool R, Dragomir A, Kulkarni GS, Breau RH, Kim M, et al. Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis. Journal of Clinical Oncology. 2025. doi:10.1200/jco.23.02718

BibTeX
@article{Marcq2025,
  author = {Marcq, Gautier and Kool, Ronald and Dragomir, Alice and Kulkarni, Girish S and Breau, Rodney H and Kim, Michael and Busca, Ionut and Abdi, Hamidreza and Dawidek, Mark and Uy, Michael and Fervaha, Gagan and Alimohamed, Nimira and Izawa, Jonathan and Jeldres, Claudio and Rendon, Ricardo and Shayegan, Bobby and Siemens, Robert and Black, Peter C and Cury, Fabio L and Kassouf, Wassim},
  title = {Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis},
  journal = {Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1200/jco.23.02718}
}
Kostenlos starten →